No Data
No Data
No Data
No Data
No Data
Lee's Pharmaceutical's 2023 Profit Slumps 67%
Lee's Pharmaceutical Holdings (HKG:0950) recorded a 67% decline in attributable profit for the year ended Dec. 31, 2023, to HK$16.7 million from HK$51.3 million in 2022, a Friday filing on the Hong Ko
MT NewswiresApr 19 08:00 ET
李氏大藥廠:2023年年報
Futu NewsApr 19 05:55 ET · Announcements
LEE'S PHARM To Go Ex-Dividend On May 28th, 2024 With 0.01 HKD Dividend Per Share
March 27th - $LEE'S PHARM(00950.HK)$ is trading ex-dividend on May 28th, 2024. Shareholders of record on May 29th, 2024 will receive 0.01 HKD dividend per share on June 17th, 2024. The ex-dividend
moomoo NewsMar 27 05:05 ET
Lee's Pharmaceuticals (00950) will pay a final dividend of HK$0.01 per share on June 17
Lee's Pharmaceutical (00950) announced that it will be distributed on June 17, 2024 until December 2023...
Zhitong FinanceMar 26 05:08 ET
Lee's Pharmaceuticals (00950.HK): Net profit of HK$16.698 million decreased by 67.4% year-on-year in 2023
Gelonghui, March 26, 丨 Lee's Pharmaceutical (00950.HK) announced that for the year ended December 31, 2023, revenue was approximately HK$1,053 million, down 14.6% year on year; profit attributable to company owners was approximately HK$166.98 million, a decrease of 67.4% year on year; basic profit per share was HK2.84 cents, with a proposed final dividend of 1 HK cent per share. During the reporting period, the Group recorded gross profit of HK$551 million, a decrease of 28.5% over the previous year, in line with the decline in sales. The Group's gross margin for the year was 52.4%, down 10.1 from 62.5% in 2022
Gelonghui FinanceMar 26 04:55 ET
李氏大藥廠:截至二零二三年十二月三十一日止年度全年業績公佈
Futu NewsMar 26 04:52 ET · Announcements
No Data
No Data